Clinical Trial Update: Renal Allograft Tolerance Through Mixed Chimerism [Phase 1, Phase 2]

View source ↗

Summary

A phased clinical trial evaluating renal allograft tolerance using mixed chimerism in patients with end-stage renal disease has completed Phase 1 and Phase 2 wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Massachusetts General Hospital | Conditions: End Stage Renal Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-09-23